Spark Therapeutics (ONCE) Reports Q1 Loss of $1.70/Share

Spark Therapeutics (NASDAQ: ONCE) reported Q1 EPS of ($1.70), versus ($0.95) reported last year. Revenue for the quarter came in at $1.27 million, versus $1.29 million reported last year.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c